Johnson & Johnson commits $5.5bn to end remaining talc litigation
The resolution comes after plaintiffs were unable to prove that J&J’s talc products caused their ovarian cancer
- News
- Research
- Sales
- Regulatory
- Healthcare
- Marketing
Pfizer’s Talzenna plus Xtandi gets FDA Priority Review for metastatic prostate cancer
The phase 3 trial showed greater than 50% improvement in radiographic progression-free survival
Lilly to acquire AtaiBeckley in deal worth $2.8bn
The acquisition will advance therapies for treatment-resistant depression and other mental health conditions
EMA recommends granting marketing authorisation approval for Nezglyal
The treatment is for cerebral adrenoleukodystrophy, a rare neurodegenerative disease
Johnson & Johnson commits $5.5bn to end remaining talc litigation
The resolution comes after plaintiffs were unable to prove that J&J’s talc products caused their ovarian cancer
MAD World Summit 2026: where the future of workplace well-being takes centre stage
The event takes place on Thursday 26 November 2026 in the heart of London at Convene, 155 Bishopsgate
Latest content
Havas Lynx expands Claire Knapp’s remit to oversee Havas Lynx New York
In addition, Bruno Rebelo is appointed to the NY office as Chief Creative Officer
Read More
ELRIG appoints Hitesh Sanganee and Marcus Schindler to Scientific Advisory Board
Sanganee and Schindler previously held senior leadership roles at AstraZeneca and Novo Nordisk, respectively
Read More
Stoke Therapeutics appoints Thomas McCauley as Chief Scientific Officer
McCauley most recently served as the President and CEO of Neptune Bio
Read More
Richmond Pharmacology appoints Daniel Chapple as Commercial Director
Chapple has held senior leadership roles at DontBePatient Intelligence, Alira Health, Innovative Trials, Cognizant and ICON
Read More
Intelligence
The UK’s life sciences’ crossroads: competing in a market defined by speed, scale and investment
The UK’s challenge is less about capability and more about how well it aligns with the way global pharma now operates
Read More
Launching into an AI-powered future: a prescription for success
Making launch more effective, precise, cost-effective and agile demands new thinking and new technologies
Read More
ASCO 2026: the art of translation
Translating emerging science into care that works meaningfully in practice
Read More
Steering generative AI into the pharma fast lane
Industry needs to press the accelerator to adopt AI across functions to
supercharge launch excellence
Bridging the gap between European brain innovation and real-world policy
Aligning policy and public funding strategies to support brain health across Europe
Read More
Obesity care in the UK – why it can’t improve until it is recognised as a disease
The WHO classified obesity as a chronic disease over twenty years ago – but UK policy has yet to follow
Read More
Blogs
Latest
The Heart of the Matter: Medscape Education’s Cardiology Footprint at ESC 2026
July 28, 2026 | Medscape Education|CME, Cardiology Education, IME, Patient Impact, cardiology
For more than 30 years, Medscape Education has built independent, accredited cardiovascular education designed around one goal: improved patient outcomes. This year at the European …
What do patient stories actually teach us?
July 21, 2026 | Mednet|Making Health Whole, Patient Stories, health communications, marketing strategy, medcomms
How do we translate individual experiences into support that helps others and create support that feels personal but remains relevant to many?
More Than Pink Walls: What Women-Centric Care Actually Requires
July 15, 2026 | Medscape Education|
The phrase “patient-centered care” is tossed around freely in healthcare corporate boardrooms. Yet, for more than half the population, that promise routinely fractures. In the …
Real Chemistry Launches Real Chemistry ANATOMI, an AI Ecosystem Purpose-Built for Healthcare Commercialization
July 14, 2026 | Real Chemistry|AI, Innovation, healthcarecommunications
The unique combination of technology marks 25 years of industry innovation and expertise, and signals company’s next phase of business growth and client value
Women in Healthcare Leadership Have a Lot to Say. Medscape’s Hear From Her Wins an APEX Grand Award.
July 2, 2026 | Medscape Education|#APEX2026
Medscape Education has been honoured with the prestigious APEX Grand Award for Publication Excellence at…
A seat at the table: what the EU HTA reforms really ask of patient involvement
July 24, 2026 | Cuttsy + Cuttsy|EU HTA, Patient involvement, clinical trials, design
The EU HTA reforms give patients a formal role in assessing new medicines, but meaningful involvement requires more than simply offering them a seat at …
Infographic: Are data blind spots putting your launch at risk?
July 16, 2026 | Inizio|AI, Pharma, Product Launch, healthcare
Commercial pharma launches depend on confident, evidence-led decisions. Yet many launch teams are still working with fragmented data spread across multiple systems, making it difficult …
Why faster trials make participant understanding more important than ever
July 15, 2026 | Cuttsy + Cuttsy|Informed Consent, clinical trials, communication
As clinical trials accelerate, clear, accessible consent is essential to help participants understand, engage with and remain in a study.
Older trial participants reject bad design, not technology
July 8, 2026 | Cuttsy + Cuttsy|Digital, clinical trials, communication, design
Older trial participants aren’t rejecting digital technology — they’re rejecting poorly designed, inaccessible experiences that make participation harder.